233 related articles for article (PubMed ID: 1773786)
21. Enhancement of lung tumor formation in mice by dietary butylated hydroxytoluene: dose-time relationships and cell kinetics.
Witschi HR; Morse CC
J Natl Cancer Inst; 1983 Oct; 71(4):859-66. PubMed ID: 6578375
[TBL] [Abstract][Full Text] [Related]
22. Quantitative trait loci that regulate susceptibility to both butylated hydroxytoluene-induced pulmonary inflammation and lung tumor promotion in CXB recombinant inbred mice.
Malkinson A; Radcliffe R; Bauer A; Dwyer-Nield L; Kleeberger S
Chest; 2002 Mar; 121(3 Suppl):82S. PubMed ID: 11893704
[No Abstract] [Full Text] [Related]
23. Modulation of the incidence of urethane induced mouse lung adenomas by butylated hydroxytoluene (BHT).
Malkinson AM
Proc West Pharmacol Soc; 1983; 26():417-9. PubMed ID: 6889373
[No Abstract] [Full Text] [Related]
24. The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice.
Bauer AK; Dwyer-Nield LD; Hankin JA; Murphy RC; Malkinson AM
Toxicology; 2001 Dec; 169(1):1-15. PubMed ID: 11696405
[TBL] [Abstract][Full Text] [Related]
25. Cells of origin of primary pulmonary neoplasms in mice: morphologic and histochemical studies.
Thaete LG; Malkinson AM
Exp Lung Res; 1991; 17(2):219-28. PubMed ID: 2050027
[TBL] [Abstract][Full Text] [Related]
26. Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion.
Bauer AK; Dwyer-Nield LD; Keil K; Koski K; Malkinson AM
Exp Lung Res; 2001; 27(3):197-216. PubMed ID: 11293324
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of early chemically-induced pulmonary lesions in mice of varying susceptibilities to lung tumorigenesis.
O'Donnell EP; Zerbe LK; Dwyer-Nield LD; Kisley LR; Malkinson AM
Cancer Lett; 2006 Sep; 241(2):197-202. PubMed ID: 16337739
[TBL] [Abstract][Full Text] [Related]
28. Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.
Karasaki H; Obata M; Ogawa K; Lee GH
Oncogene; 1997 Oct; 15(15):1833-40. PubMed ID: 9362450
[TBL] [Abstract][Full Text] [Related]
29. Butylhydroxytoluene (BHT) increases susceptibility of transgenic rasH2 mice to lung carcinogenesis.
Umemura T; Kodama Y; Hioki K; Inoue T; Nomura T; Kurokawa Y
J Cancer Res Clin Oncol; 2001 Oct; 127(10):583-90. PubMed ID: 11599794
[TBL] [Abstract][Full Text] [Related]
30. The genetic basis of susceptibility to lung tumors in mice.
Malkinson AM
Toxicology; 1989 Mar; 54(3):241-71. PubMed ID: 2650016
[TBL] [Abstract][Full Text] [Related]
31. The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility.
Chen B; Johanson L; Wiest JS; Anderson MW; You M
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1589-93. PubMed ID: 8108449
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions.
Wardlaw SA; March TH; Belinsky SA
Carcinogenesis; 2000 Jul; 21(7):1371-7. PubMed ID: 10874016
[TBL] [Abstract][Full Text] [Related]
33. Cell kinetics in mouse lung following administration of carcinogens and butylated hydroxytoluene.
Witschi HP; Morse CC
Toxicol Appl Pharmacol; 1985 May; 78(3):464-72. PubMed ID: 4049395
[TBL] [Abstract][Full Text] [Related]
34. Analysis of lung tumorigenesis in chimeric mice indicates the Pulmonary adenoma resistance 2 (Par2) locus to operate in the tumor-initiation stage in a cell-autonomous manner: detection of polymorphisms in the Poli gene as a candidate for Par2.
Lee GH; Nishimori H; Sasaki Y; Matsushita H; Kitagawa T; Tokino T
Oncogene; 2003 Apr; 22(15):2374-82. PubMed ID: 12700672
[TBL] [Abstract][Full Text] [Related]
35. Effects of adrenalectomy and corticosterone administration on mouse lung tumor susceptibility and histogenesis.
Droms KA; Fernandez CA; Thaete LG; Malkinson AM
J Natl Cancer Inst; 1988 May; 80(5):365-9. PubMed ID: 2895816
[TBL] [Abstract][Full Text] [Related]
36. Metabolic activation of butylated hydroxytoluene by mouse bronchiolar Clara cells.
Bolton JL; Thompson JA; Allentoff AJ; Miley FB; Malkinson AM
Toxicol Appl Pharmacol; 1993 Nov; 123(1):43-9. PubMed ID: 8236260
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
[TBL] [Abstract][Full Text] [Related]
38. Protein damage from electrophiles and oxidants in lungs of mice chronically exposed to the tumor promoter butylated hydroxytoluene.
Shearn CT; Fritz KS; Thompson JA
Chem Biol Interact; 2011 Jul; 192(3):278-86. PubMed ID: 21536018
[TBL] [Abstract][Full Text] [Related]
39. Very early changes in pulmonary protein kinase C-alpha and calpain II contents following injection of butylated hydroxytoluene (BHT) into mice.
Miller AC; Dwyer-Nield LD; Malkinson AM
Toxicology; 1995 Mar; 97(1-3):141-9. PubMed ID: 7716780
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of glucocorticoid involvement in mouse lung tumorigenesis.
Droms KA; Malkinson AM
Exp Lung Res; 1991; 17(2):359-70. PubMed ID: 2050036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
